The present invention relates to the use of (.+-.)-R*,S*)-alpha-2-piperidnyl-2,8-bis(trifluoromethyl)-4-quinolinemthanol and in particular (-)-(11S,2'R)-alpha-2-piperidnyl-2,8-bis(trifluoromethyl)-4-quinolinemthanol in the treatment of disorders in which the reduction of purinergic neurotransmission...http://www.google.es/patents/US6197788?utm_source=gb-gplus-sharePatente US6197788 - (-)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders
(-)-mefloquine to block puringergic receptors and to treat movement or ...
